COPD stage-dependent prevalence of PAD with special consideration of inflammation and exacerbation rate
- Conditions
- I70.2J44.9Atherosclerosis of arteries of extremitiesChronic obstructive pulmonary disease, unspecified
- Registration Number
- DRKS00023759
- Lead Sponsor
- Praxis RechPneumologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Patient capable of giving consent
Diagnosed with COPD
Exclusion Criteria
Other lung diseases
Serious comorbidities
Incapable of giving consent / persons under 18 years of age.
pregnancy
Tumor therapy
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The anamnesis is followed by the ABI (Ankle Brachial Index) measurement, lung function test, determination of the walking distance ( 6 minutes’ walk distance) and <br>measurement of hsCRP in serum<br>The study is designed for a period of 6-12 months or a case number of 200 patients.<br>The primary endpoint is the answer to the question of whether a PAD is present and the assignment to a stage of the PAD
- Secondary Outcome Measures
Name Time Method <br>How high is the unreported number of PAD in COPD patients. Which screening methods are useful in the routine for patients with COPD with regard to the question of the presence of PAD?